GATD3

Glutamine amidotransferase-like class 1 domain-containing protein 3, mitochondrial · P0DPI2 · GATD3 on Sugi Atlas →

0 patent compounds predicted against GATD3, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to GATD3 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Pharmacogenetic Treatment With Anti-Glutaminergic Agents for Comorbid PTSD & AUD PHASE3COMPLETED
Effect of Sarcosine on Symptomatology, Quality of Life, Oxidative Stress and Glutamatergic Parameters in Schizophrenia PHASE2COMPLETED
Therapeutic Efficacy of L-Ornithine L-Aspartate Infusion in Patients With Acute Liver Failure PHASE2UNKNOWN
Anaplerotic Therapy in Propionic Acidemia PHASE1COMPLETED
Tolerability of Enteral NAC in Infants PHASE1NOT_YET_RECRUITING
Phenylbutyrate for Monogenetic Developmental and Epileptic Encephalopathy EARLY_PHASE1ACTIVE_NOT_RECRUITING
Biomarker for Creatine Deficiency Syndromes (BioCDS) nanWITHDRAWN
Acute Glycine Pharmacodynamic Study nanCOMPLETED
Effect of Nutritional Supplementation and Pulmonary Rehabilitation on the Clinical Status of HF and COPD nanUNKNOWN
Risk Factors for the Development of Celiac Disease in Genetically Predisposed Children nanUNKNOWN
Oral Glutamine in Cardiopulmonary Bypass nanCOMPLETED
Transcriptomic Profile of Patients Treated With Different Modalities of Spinal Cord Stimulation nanUNKNOWN
Natural History and Biospecimen Acquisition for Children and Adults With Rare Solid Tumors nanRECRUITING
Assessing the Polygenic Burden of Rare Disruptive Mutations in Parkinson's Disease nanUNKNOWN
A Study of Cases with Abnormal Serum Ammonia in Neonate and Children Attending Assiut University Children Hospital nanNOT_YET_RECRUITING
Investigating Phenotypic, Epigenetic, and NeuroGenetic Traits in Rare and Ultra-rare Neurodevelopmental Disorders (Project PENGUIN) nanRECRUITING
Natural History Study of SLC25A46 Mutation-related Mitochondriopathy nanCOMPLETED
Biomarker Research in Inherited Movement Disorders nanRECRUITING
Genetic Risk for Attention Deficit Hyperactivity Disorder Expressed in Brain Functioning nanUNKNOWN
Study of Chediak-Higashi Syndrome nanRECRUITING
Nitric Oxide Supplementation on Neurocognitive Functions in Patients With ASLD nanCOMPLETED
Predisposition Genes in Monogenic Diabetes (DIAMONO) nanCOMPLETED
Genetics of Epilepsy and Related Disorders nanRECRUITING
Inherited Reproductive Disorders nanRECRUITING
Phenotypic and Genotypic Studies in Congenital and Early Onset Ataxias nanCOMPLETED
Genetic Studies of Lysosomal Storage Disorders nanENROLLING_BY_INVITATION
Identification of Genetic Basis of Atrioventricular Conduction Defects: From Congenital Forms to Degenerative Forms nanUNKNOWN
EXtremely Early-onset Type 1 Diabetes EXtremely Early-onset Type 1 Diabetes (A Musketeers' Memorandum Study) nanRECRUITING
Investigating the Genetic Basis of Pseudoexfoliation Syndrome, Angle-closure Glaucoma and Primary Open-angle Glaucoma nanRECRUITING
Decoding the Genetic Landscape of Skeletal Diseases nanRECRUITING

Related proteins — ESM-2 sequence neighbours (a GATD3 binder may also engage these)

ProteinNameSimilarity
Q9D172 0.996 Q9D172 →
P56571 0.990 P56571 →
F1QCN0 0.978 F1QCN0 →
Q6ZL94 0.963 Q6ZL94 →
W5PFI3 0.962 W5PFI3 →
Q58DR8 0.959 Q58DR8 →
Q8LAD2 0.959 Q8LAD2 →
NNT NAD(P) transhydrogenase, mitochondrial 0.959 landscape →
Q9WUM5 0.958 Q9WUM5 →
O19069 0.956 O19069 →
Q93ZR1 0.956 Q93ZR1 →
P13086 0.956 P13086 →
SUCLG1 Succinate--CoA ligase [ADP/GDP-forming] subunit alpha, mitochondrial 0.955 landscape →
Q8GTQ9 0.955 Q8GTQ9 →
Q49KG0 0.953 Q49KG0 →
A7M6E8 0.953 A7M6E8 →
B1XC09 0.952 B1XC09 →
B8EQC8 0.952 B8EQC8 →
A8A7A6 0.951 A8A7A6 →
B7MIZ2 0.951 B7MIZ2 →
Q5R514 0.951 Q5R514 →
B5XQJ3 0.951 B5XQJ3 →
Q94AR8 0.951 Q94AR8 →
P13439 0.951 P13439 →
A3PRB5 0.950 A3PRB5 →
P11024 0.950 P11024 →
P68209 0.950 P68209 →
A7M6E7 0.950 A7M6E7 →
Q3IXP4 0.950 Q3IXP4 →
Q5RFI8 0.950 Q5RFI8 →